United States
Germany
Japan
United Kingdom
China
KHK - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Products
KHK (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
KHK - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
KHK - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
KHK CRISPRa kit - CRISPR gene activation of human ketohexokinase
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Ketohexokinase (1-298) human recombinant protein, 0.1 mg
| Expression Host | E. coli |
Ketohexokinase (1-298) human recombinant protein, 0.5 mg
| Expression Host | E. coli |
qSTAR qPCR primer pairs against Homo sapiens gene KHK
3' UTR clone of ketohexokinase (fructokinase) (KHK) transcript variant b for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
qPCR primer pairs and template standards against Homo sapiens gene KHK
| Application | Plasmid of exact quantity for transcript copy number calculation |
3' UTR clone of ketohexokinase (fructokinase) (KHK) transcript variant a for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
